跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Miodazen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Miodazen
Approved
STANDARD
Miodazen
Stallion Laboratories Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e4f545b6e5415a40
Company
Stallion Laboratories Pvt. Ltd
Type
Standard
Approval Details
Approval Id
e4f545b6e5415a40
Drug Approval Philippines Name
Miodazen
Product Name
Miodazen
Registration Number
DRP-3391-04
Brand Name
Miodazen
Generic Name
Amiodarone Hydrochloride
Dosage Form
Tablet
Dosage Strength
200 mg
Manufacturer
Stallion Laboratories Pvt. Ltd
Importer
Ambica International Corporation
Distributor
Kodapharm Med Corp
Issuance Date
27 October 2024
Expiry Date
21 November 2029
Pharmacologic Category
Anti-arrhythmic Agent
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e4f545b6e5415a40
Type
Standard
Back to Philippines FDA Approvals